Followers | 1080 |
Posts | 80410 |
Boards Moderated | 9 |
Alias Born | 03/10/2009 |
![](https://investorshub.advfn.com/uicon/145719.png?cb=1567961125)
Monday, August 29, 2022 1:31:49 PM
additional information aboutADR
(ANPC)
TradeSet AlertAdd to Watchlist
Biotechnology
NASDAQ
$0.2548
Today's Change
$0.0047(+1.88%)
ADR Ratio
1:1
Bid/Size
$0.2547/1
Ask/Size
$0.2597/6
Today's Volume
1.1M
Today's Range
$0.25$0.2699
52 Week Range
$0.2022$4.01
Today's Open
$0.26
Previous Close
$0.2501
Quote as of 1:09 PM ET, 08/29/2022
You may be charged fees by the Bank that custodies this ADR. Read More about ADR pass-through fees.
This stock may be available for trading through a Schwab Global Account. Learn More
Margin Requirements
Chart
zoom
toggle
Show events
-3.18 (-92.57%)
Disclosures
Technicals
toggle
Indicators Table
Beta (5 Year) On Balance Volume RSI (14-Day)
-- Trending Higher 47.34
Averages Table
10-Day Average Volume 12,972,280
90-Day Average Volume 2,199,015
20-Day Moving Average $0.26
50-Day Moving Average $0.28
200-Day Moving Average $0.65
Historical Volatility (10 Day) 138.07%
Previous analysis slide
Trend Analysis
ANPC appears to be rallying within a longer-term bearish trend, driving its MACD above the signal line. However, shares remain below a declining 200-day moving average, signifying that the dominant trend remains lower. Comparative Relative Strength analysis shows that this issue is lagging the S&P 500.
As of 1:09 PM ET Monday, 08/29/2022
Momentum
Momentum for ANPC is strongly bearish. The 14-period Slow Stochastic oscillator is below 20, the level which many analysts call oversold. This means that investors have been actively selling shares and driving the price lower.
As of 1:09 PM ET Monday, 08/29/2022
Volume
Today's volume is on track to be lighter than usual, with 1,087,493 shares having traded so far. The On Balance Volume indicator (OBV) is bullish. The slope of the indicator is positive and suggests that buyers are presently more active than sellers.
As of 1:09 PM ET Monday, 08/29/2022
Volatility
Bollinger Bands® use standard deviation of the closing price around a moving average to measure volatility. The Bollinger Bands® are presently wider than usual, as a result of greater than normal volatility that accompanied the recent price move. Events such as this may precede a pause or reversal in the near term trend.
As of 1:09 PM ET Monday, 08/29/2022
Next analysis slide
Disclosures
Expected Earnings
zoom
toggle
Upcoming Earnings
Chart currently unavailable
Next Earnings Announcement
09/02/2022
Time of Release
After Market Close
Consensus Estimate (Q2 2022)
--
Historical Earnings
Chart currently unavailable
Non-GAAP (Q1 2022)
--
Consensus Estimate (Q1 2022)
--
Revenue (TTM)
$2.60M
Price/Earnings (TTM)
--
Forward P/E
--
Price to Earnings/Growth (PEG)
--
Disclosures
Dividends
zoom
toggle
The security does not currently pay a dividend
Disclosures
Peers & Ratios Comparison
zoom
toggle
Overview Table
ANPC BRTX DFFN YTEN CLSN
Company Name AnPac Bio-Medical Science Co Ltd BioRestorative Therapies Inc Diffusion Pharmaceuticals Inc Yield10 Bioscience Inc Celsion Corp
Schwab Equity Rating®* Opens a new window with more information about Schwab Equity Rating NC
Opens a new window with more information about Schwab Equity Rating NC
Opens a new window with more information about Schwab Equity Rating NC
Opens a new window with more information about Schwab Equity Rating NC
Opens a new window with more information about Schwab Equity Rating NC
Last Price $0.25 $3.32 $6.65 $3.16 $2.22
Market Cap $6M $12M $13M $15M $16M
Price / Earnings (TTM) -- -- -- -- --
Annual Dividend Yield -- -- -- -- --
EPS Growth Forecast - 3-5 Year -- -- -- -- --
Net Profit Margin -595.09% -34,044.71% -- -2,450.00% -5,229.82%
*Schwab Equity Rating based on data as of 08/26/2022 market close.
**Not Currently Rated By Reuters.
Statements
zoom
toggle
Converted Values in $USD
Statements Result Table
Balance Sheet
(Fiscal Year Ending in December)
Annual
Trend
2021
12/31/2021
2020
12/31/2020
2019
12/31/2019
2018
12/31/2018
2017
12/31/2017
Total Current Assets
Chart for Total Current Assets annual trend. 3.70 3.26 3.18 3.03 2.72
Total Assets
Chart for Total Assets annual trend. 10.62 7.64 7.61 7.67 9.10
Total Current Liabilities
Chart for Total Current Liabilities annual trend. 9.90 6.67 9.51 10.39 5.35
Total Debt
Chart for Total Debt annual trend. 5.31 1.26 5.54 3.77 1.89
Total Liabilities
Chart for Total Liabilities annual trend. 11.33 7.19 9.90 10.93 7.66
Total Equity
Chart for Total Equity annual trend. (0.71) 0.45 (2.29) (3.26) 1.45
Total Liabilities & Shareholders' Equity
Chart for Total Liabilities & Shareholders' Equity annual trend. 10.62 7.64 7.61 7.67 9.10
Values are in Millions, except for per share data.
Years are Fiscal Years. () = Negative
Disclosures
Ratings
toggle
Schwab Equity Rating®
No rating provided by Schwab.
MSCI LogoESG RatingNo rating provided by MSCI.Learn more about MSCI’s ratings methodologies
Morning Star LogoNo Morningstar Rating available.
Credit Suisse LogoNo rating provided by Credit Suisse.View all Credit Suisse Research Reports
Thomson Reuters Logo
As of 03/31/2020
SellUnderperformHoldSelected Value:OutperformBuy
Reuters Investment Profile
Reuters maintains a current price target of $18.00 for ANPC.
CFRA LogoNo ranking provided by CFRA
Argus LogoNo rating provided by Argus
Market Edge LogoNo rating provided by Market Edge
1 Ratings are specific to each type of security. Equities display Schwab Equity Ratings®, ETFs & Closed End Funds display a link to Morningstar ratings, Mutual Funds display Morningstar ratings, and Fixed Income displays S&P followed by Moody's ratings.
Disclosures
ETFs Holding This Company
toggle
No ETFs Available
Stay Connected™
toggle
Settings
current slide 1
Reuters Investment Profile Report now available
On Aug 26, 2022 Reuters released an updated analyst report.
View Report
Q2 2022 Earnings Expected 09/02/2022
Price Crossed Below 50-Day Moving Average 08/26/2022
Disclosures
Company Profile
zoom
toggle
Business Summary
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China.
Show More
Website
www.anpacbio.com
STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS
http://investorshub.advfn.com/boards/board.aspx?board_id=19627
My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Recent ANPC News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/26/2024 12:00:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 12:03:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2024 08:23:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/02/2024 01:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2024 08:12:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2024 08:06:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/25/2024 08:05:33 PM
- Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 03/25/2024 08:02:21 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM